Your Top 10 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study

Benjamin Solomon, Geoffrey Liu, Enriqueta Felip, Tony S.K. Mok, Ross Andrew Soo, Julien Mazières and 12 more

Rank
1 of 493
Percentile
top 0.3%
Where
Journal of Clinical Oncology, 2024
Citations
383

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.